Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) just unveiled an update.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced the evaluation of its 2024 Action Plan and introduced its 2025 Action Plan, both aimed at quality improvement, efficiency enhancement, and shareholder returns. The company has aligned its strategies with national and Shanghai Stock Exchange initiatives to strengthen corporate governance, enhance productivity, and improve investor communication, thereby promoting high-quality development and better shareholder returns.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in China, operating in the pharmaceutical industry. The company focuses on quality improvement, efficiency enhancement, and shareholder returns, aligning with initiatives from the Shanghai Stock Exchange.
For detailed information about 2TZ stock, go to TipRanks’ Stock Analysis page.